Lucasbio
Clinical trials sponsored by Lucasbio, explained in plain language.
-
Boosting the immune system after transplant: could 'Killer' cells prevent relapse?
Disease control CompletedThis study tests whether giving patients their own specially grown immune cells (called cytokine-induced killer cells) shortly after a stem cell transplant is safe. The trial enrolls adults with lymphoma who are receiving a transplant of their own stem cells. Researchers will mon…
Phase: NA • Sponsor: LucasBio • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Personalized immune cell therapy aims to clear stubborn COVID-19 infections
Disease control CompletedThis study tests a treatment called LB-DTK-COV19, made from a patient's own immune cells, for people who have had COVID-19 symptoms or a positive test for more than 21 days. Participants receive two infusions of their personalized T cells, two weeks apart, and are followed for si…
Phase: NA • Sponsor: LucasBio • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC